FIP Honourary President Passes Away at the Age of 74
Thursday, 21st September, 2006: It is with great sadness that FIP must announce the passing away of Dr Nils-Olaf (Nippe) Strandqvist, Honourary President of FIP, on Saturday, 16th September, at the age of 74.
Dr Strandqvist obtained his Pharmacist degree in Stockholm in 1959 and began his career working in industry and community pharmacy.
A true leader from the beginning, from 1956-1957 Dr Strandqvist served as the President of the Swedish Pharmaceutical Students´ Association, and went on to take up the role as the President of the Swedish Pharmaceutical Association, twice over, from1970-1975 and again for the 1979-1983 term. This experience further lead him to become a Vice-President of FIP from 1986-1990, and in turn be elected as President in 1990, following through as Immediate Past–President and Chairman of the FIP Foundation. He became widely known for his continuous, active involvement in many aspects of the profession, both at national and international levels. In 1998 he was appointed as an Honourary President of FIP, and was granted Honourary Memberships to many National Pharmacy Organisations. He also received an Honourary Doctorate from the Hoshi University in Tokyo.
After his retirement Dr. Strandqvist continuously made available his professional skills and knowledge to those areas of the profession where they were most needed. He is considered one of the Founding Fathers of the FIP-WHO Good Pharmacy Practice Project, having had a great impact on bringing the project to fruition. He was active in Pharmaciens Sans Frontières (PSF –Pharmacists without Borders) and was always prepared to provide solid advice to new generations of pharmacy leaders.
In recognition of all his remarkable achievements, Dr. Strandqvist was bestowed the Andre Bedat Award in 2002, FIP’s highest professional award. By his work and by all who knew him, Nippe Strandqvist will be remembered as a warm and caring personality, who always showed a sincere interest in the personal wellbeing of those who had the pleasure of working with him.
FIP would like to extend sincere condolences to the children and grand children whom he loved so dearly, and further family of Dr Strandqvist, with great appreciation of his contribution to FIP and the international Pharmacy community.